Background Valvular heart disease (VHD) represents a significant burden on healthcare systems worldwide, necessitating ...

For years, it was shrouded in secrecy. It was heart surgery’s Manhattan Project, whispered to be set to change the world. And ...

The preliminary data open the door to an alternative approach to invasive monitoring in heart failure patients.

Abbott has taken a step forward in the development of a new addition to its structural heart portfolio, completing the first ...

Abbott Announces First Step Toward Its Software-Guided Balloon-Expandable TAVI System to Treat Aortic Stenosis • The investigational transcatheter aortic valve implantation (TAVI) system will ...

The Fred & Lena Meijer Heart Center turns 20 in November and Corewell Health is looking back at all the milestones.

Abbott today announced the first patient procedures with its investigational transcatheter aortic valve implantation (TAVI) ...

Abbott (NYSE: ABT) today announced the first patient procedures with its investigational transcatheter aortic valve implantation (TAVI) balloon-expandable system for treating symptomatic severe aortic ...

With restored circulation, the TAH allowed Harbison to regain enough strength within 10 days to also undergo a heart ...

Researchers at Penn State are using machine learning and existing electrocardiogram (ECG) data to help doctors make more ...

This historical growth is driven by an aging population leading to a rise in valvular heart disease, an increase in risk factors such as obesity and hypertension, advancements in diagnostic and ...